Oral contraceptives may increase risk for developing gliomas
the ONA take:
According to a new study published in the British Journal of Clinical Pharmacology, researchers have found that certain forms of birth control may increase the risk for developing a glioma, a rare brain cancer.
For the study, researchers analyzed data from Denmark's national registries of health records, cancer cases, and prescriptions in order to identify women aged 15 to 49 years diagnosed with glioma and which women were prescribed contraceptives.
Results showed that women who had used hormonal contraceptives (estrogen, progestin, or both) had a 50% increased risk for developing gliomas compared with those who did not take hormonal contraceptives. In addition, women who used birth control for greater than 5 years had a nearly 200% increased risk for developing gliomas.
Women taking progestin-only contraceptives were at a slightly higher risk for developing the brain cancer than those who took estrogen only or both. The researchers note that although the risk is doubled, the cancer is still rare. Specifically, among Danish women aged 15 to 49 years, only five in 100,000 will develop a glioma.
The results of the study were surprising as previous studies have found that estrogen and progestin may decrease the risk of gliomas, but particularly in post-menopausal women.
Certain forms of birth control may increase the risk for developing a glioma, a rare brain cancer.
Sign Up for Free e-newsletters
- Chemotherapy-Related Fatigue Linked to Levothyroxine Use in Breast Cancer
- New Hypertension Threshold Guides Blood Pressure Management During Cancer Treatment
- Sexual Aids and Resources Not Readily Available at Cancer Centers
- Gas Mixture Improves Efficacy of Breakthrough Cancer Pain Treatment
- Factors Affecting Employment Participation in Early-stage Breast Cancer
- Sitting With Silence in End-of-Life Cancer Care
- Obesity and Cancer Risk (Fact Sheet)
- Susceptibility Gene Mutations Common in Those With Pancreatic Cancer and History of Other Cancers
- Anticancer Properties of Omega-3 Fatty Acids: Plant-Based vs Marine-Based
- US Pharmacopeia Revises Chapter on Handling Hazardous Drugs
- Adjuvant Vemurafenib Does Not Improve Disease-Free Survival in Melanoma
- Profile of Buparlisib and its Potential in the Treatment of Breast Cancer: Evidence to Date
- Exercise Before Lung Cancer Surgery Greatly Reduces Complications
- Hodgkin Lymphoma Treatment in EU vs US: Similarities Would Enable Worldwide Studies
- Zinc Sulfate Improves Chemotherapy-Induced Mucositis Outcomes in Leukemia
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|